Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.
Clinical trial NCT04711902 · COMPLETED
Trial details
- NCT number
- NCT04711902
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-24
- Primary completion
- 2022-06-02
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.